Cours Oncology Pharma Inc. Other OTC
Actions
ONPH
US68235J2015
Produits pharmaceutiques
CA 2003 | 3,28 M 2,97 M | CA 2004 | 1,18 M 1,07 M | Capitalisation | 3,87 k 3,5 k |
---|---|---|---|---|---|
Résultat net 2003 | -1 M -905 k | Résultat net 2004 | -1 M -905 k | VE / CA 2003 | - |
Trésorerie nette 2003 | 1,35 M 1,22 M | Dette nette 2004 | 17 k 15,38 k | VE / CA 2004 | - |
PER 2003 * |
-
| PER 2004 |
-
| Employés | - |
Rendement 2003 * |
-
| Rendement 2004 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
George Malesek
CEO | Chief Executive Officer | - | - |
James B. Smith
DFI | Director of Finance/CFO | - | 28/01/21 |
Charles Wagner
CHM | Chairman | - | 30/09/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Stefan Gruenwald
BRD | Director/Board Member | - | 08/10/19 |
Charles Wagner
CHM | Chairman | - | 30/09/14 |
Carlos Barnett
BRD | Director/Board Member | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+26,08% | 681 Md | |
+21,85% | 556 Md | |
-4,77% | 361 Md | |
+16,97% | 325 Md | |
+5,69% | 285 Md | |
+13,68% | 235 Md | |
+3,65% | 199 Md | |
-11,12% | 189 Md | |
-3,40% | 157 Md |